🐜
|
The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells.
14 auth.
L. de Leval,
D. Rickman,
C. Thielen,
A. Reyniès,
Yenlin Huang,
G. Delsol,
L. Lamant,
K. Leroy,
J. Brière,
T. Molina,
...
F. Berger,
C. Gisselbrecht,
L. Xerri,
P. Gaulard
|
9 |
2007 |
9 🐜
|
🐜
|
Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy
13 auth.
Hongxiang Liu,
Agnes Ruskon-Fourmestraux,
A. Lavergne‐Slove,
H. Ye,
T. Molina,
Y. Bouhnik,
R. Hamoudi,
T. Diss,
A. Doğan,
F. Mégraud,
...
J. Rambaud,
M. Du,
P. Isaacson
|
8 |
2001 |
8 🐜
|
🐜
|
Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations.
18 auth.
N. Jeremiah,
B. Neven,
M. Gentili,
I. Callebaut,
S. Maschalidi,
M. Stolzenberg,
Nicolas Goudin,
M. Frémond,
P. Nitschké,
T. Molina,
...
S. Blanche,
C. Picard,
G. Rice,
Y. Crow,
N. Manel,
A. Fischer,
B. Bader-Meunier,
F. Rieux-Laucat
|
8 |
2014 |
8 🐜
|
🐜
|
T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication.
21 auth.
Hongxiang Liu,
H. Ye,
A. Ruskoné-Fourmestraux,
D. de Jong,
S. Pileri,
C. Thiede,
A. Lavergne,
H. Boot,
G. Caletti,
T. Wündisch,
...
T. Molina,
B. Taal,
S. Elena,
Togliani Thomas,
P. Zinzani,
A. Neubauer,
M. Stolte,
R. Hamoudi,
A. Dogan,
P. Isaacson,
M. Du
|
8 |
2001 |
8 🐜
|
🐜
|
Retracted: Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)
18 auth.
D. de Jong,
A. Rosenwald,
M. Chhanabhai,
P. Gaulard,
W. Klapper,
Abigail M. Lee,
B. Sander,
C. Thorns,
E. Campo,
T. Molina,
...
A. Norton,
A. Hagenbeek,
S. Horning,
A. Lister,
J. Raemaekers,
R. Gascoyne,
G. Salles,
E. Weller
|
8 |
2007 |
8 🐜
|
🐜
|
Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma.
12 auth.
H. Tilly,
É. Lepage,
B. Coiffier,
M. Blanc,
R. Herbrecht,
A. Bosly,
...
M. Attal,
G. Fillet,
C. Guettier,
T. Molina,
C. Gisselbrecht,
F. Reyes
|
8 |
2003 |
8 🐜
|
🐜
|
Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial
22 auth.
C. Récher,
B. Coiffier,
C. Haioun,
T. Molina,
C. Fermé,
O. Casasnovas,
C. Thieblemont,
A. Bosly,
G. Laurent,
F. Morschhauser,
...
H. Ghesquières,
F. Jardin,
S. Bologna,
C. Fruchart,
B. Corront,
J. Gabarre,
C. Bonnet,
M. Janvier,
D. Canioni,
J. Jais,
G. Salles,
H. Tilly
|
8 |
2011 |
8 🐜
|
🐜
|
ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma.
12 auth.
F. Reyes,
É. Lepage,
G. Ganem,
T. Molina,
P. Brice,
B. Coiffier,
...
P. Morel,
C. Fermé,
A. Bosly,
P. Lederlin,
G. Laurent,
H. Tilly
|
8 |
2005 |
8 🐜
|
🐜
|
Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non‐small‐cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method
10 auth.
V. Hofman,
M. Ilié,
É. Long,
E. Selva,
C. Bonnetaud,
T. Molina,
...
N. Vénissac,
J. Mouroux,
P. Vielh,
P. Hofman
|
8 |
2011 |
8 🐜
|
🐜
|
Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936
33 auth.
P. Evans,
C. Pott,
P. Groenen,
G. Salles,
F. Davi,
F. Berger,
Juan F. García,
J. Krieken,
S. Pals,
P. Kluin,
E. Schuuring,
M. Spaargaren,
E. Boone,
D. Gonzalez,
B. Martínez,
...
R. Villuendas,
Paula Gameiro,
T. Diss,
K. Mills,
Gareth J. Morgan,
G. Carter,
B. Milner,
D. Pearson,
Michelle Hummel,
W. Jung,
M. Ott,
D. Canioni,
K. Beldjord,
C. Bastard,
M. Delfau-Larue,
J. Dongen,
T. Molina,
J. Cabeçadas
|
8 |
2007 |
8 🐜
|
🐜
|
Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker
19 auth.
V. Hofman,
C. Bonnetaud,
M. Ilié,
P. Vielh,
J. Vignaud,
J. Fléjou,
S. Lantuejoul,
E. Piaton,
N. Mourad,
C. Butori,
...
E. Selva,
M. Poudenx,
S. Sibon,
S. Kelhef,
N. Vénissac,
J. Jais,
J. Mouroux,
T. Molina,
P. Hofman
|
8 |
2010 |
8 🐜
|
🐜
|
Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pyloritreatment
8 auth.
A. Ruskoné-Fourmestraux,
A. Lavergne,
P. Aegerter,
F. Mégraud,
L. Palazzo,
A. Mascarel,
...
T. Molina,
J. Rambaud
|
8 |
2001 |
8 🐜
|